Biolase (BIOL) Reports Q3 Loss of $0.07/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- Intel shares fall as competitor reports record results
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
BIOLASE Reports 2016 Third Quarter and Nine-Month Results
November 8, 2016 4:05 PM ESTIRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for the third quarter and nine months ended September 30, 2016.
2016 Third Quarter highlights with comparisons to 2015 Third Quarter include:
Worldwide revenue of $13.2 million increased $2.0 million, or 18%, with a 33% increase in U.S. sales and a 4% decrease internationally WaterLase® revenue increased 77% in the U.S. and decreased 1% internationally EPIC® revenue increased 10% in the U.S. and 2% internationally Quarterly average... More


